Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Decreased insulin sensitivity of forearm muscle in myotonic dystrophy.
R T Moxley III, … , B E Herr, R Thiel
R T Moxley III, … , B E Herr, R Thiel
Published October 1, 1978
Citation Information: J Clin Invest. 1978;62(4):857-867. https://doi.org/10.1172/JCI109198.
View: Text | PDF
Research Article

Decreased insulin sensitivity of forearm muscle in myotonic dystrophy.

  • Text
  • PDF
Abstract

Previous studies of patients with myotonic dystrophy have demonstrated hyperinsulinism after glucose loading. This hyperinsulinism has been attributed by some investigators to tissue insulin resistance. We have directly studied insulin sensitivity of forearm muscle in patients having such hyperinsulinism. The effect of an intrabrachial arterial insulin infusion (100 mu U/kg per min) on glucose uptake was determined in six cases of myotonic dystrophy, six normal subjects, and in seven disease control subjects with myotonia or wasting from other disorders. There was no significant difference in insulin tolerance comparing myotonic dystrophy patients to the normal and disease control groups. Glucose tolerance and basal insulin levels were normal in the myotonic dystrophy patients, but hyperinsulinism occurred after glucose ingestion. After 25 min of intra-arterial insulin, the mean peak muscle glucose uptake in myotonic dystrophy was 2.54 +/- 0.54 mu mol/min per 100 ml forearm compared to 5.24 +/- 0.86 mu mol/min per 100 ml for disease controls (P is less than 0.05). Myotonic dystrophy patients showed a peak glucose uptake increment of only 2.6 +/- 0.2-fold over basal contrasted with the disease control value of 6.5 +/- 1.0-fold (P is less than 0.02) and the normal control value of 8.8 +/- 1.1-fold (P is less than 0.01). Thus, there was an absolute as well as a relative decrease in muscle insulin sensitivity in myotonic dystrophy patients compared to both control groups. The peak increments in arterio-superficial venous glucose concentration differences after insulin infusion were not significantly different comparing myotonic dystrophy and control groups. These data suggest that in myotonic dystrophy, there is insulin insensitivity of skeletal muscle.

Authors

R T Moxley III, R C Griggs, D Goldblatt, V VanGelder, B E Herr, R Thiel

×

Total citations by year

Year: 2025 2024 2021 2020 2019 2018 2017 2015 2014 2013 2012 2011 2010 2009 2007 2006 2004 2001 2000 1999 1998 1994 1993 1991 1990 1986 1985 1984 1983 1982 1981 1980 1978 Total
Citations: 2 2 2 1 1 1 1 2 1 1 1 4 1 4 3 2 1 1 2 1 1 1 2 2 2 3 2 2 1 2 2 2 1 57
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (57)

Title and authors Publication Year
Skeletal muscle disorders as risk factors for type 2 diabetes
Tammineni ER, Manno C, Oza G, Figueroa L
Molecular and cellular endocrinology 2025
Use of HSALR female mice as a model for the study of myotonic dystrophy type I
Carrascosa-Sàez M, Colom-Rodrigo A, González-Martínez I, Pérez-Gómez R, García-Rey A, Piqueras-Losilla D, Ballestar A, Llamusí B, Cerro-Herreros E, Artero R
Lab Animal 2025
David Goldblatt (1930-2007).
Triarhou LC
Journal of neurology 2024
Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1.
Takada H, Matsumura T, Shimamura H, Matsui M, Kon S, Fukumoto A, Kubota T, Yoshida K, Iwahashi H, Takahashi MP
Journal of clinical medicine 2024
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
J Liu, ZN Guo, XL Yan, Y Yang, S Huang
Frontiers in aging neuroscience 2021
Endocrine Dysfunction in Patients With Myotonic Dystrophy
SJ Winters
The Journal of clinical endocrinology and metabolism 2021
Cellular Mechanics and Biophysics: Structure and Function of Basic Cellular Components Regulating Cell Mechanics
CT Mierke
2020
Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1
S Nieuwenhuis, K Okkersen, J Widomska, P Blom, , B van Engelen, JC Glennon
Frontiers in neurology 2019
Diversification of the muscle proteome through alternative splicing
K Nakka, C Ghigna, D Gabellini, FJ Dilworth
Skeletal Muscle 2018
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle
LV Renna, F Bosè, S Iachettini, B Fossati, L Saraceno, V Milani, R Colombo, G Meola, R Cardani, V Mouly
PloS one 2017
Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics: DM1 disease mechanisms and therapeutics
A Chau, A Kalsotra
Developmental Dynamics 2015
Surgical treatment of obesity in DM1 – a case report and a review of the literature
K Håkansson, S Kostic, C Lindberg
Neuromuscular Disorders 2015
Myotonic Dystrophy
CA Thornton
Neurologic Clinics 2014
Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron
GV Echeverria, TA Cooper
Nucleic Acids Research 2013
RNA-binding proteins in microsatellite expansion disorders: Mediators of RNA toxicity
GV Echeverria, TA Cooper
Brain Research 2012
Handbook of Clinical Neurology
T Ashizawa, PS Sarkar
Muscular Dystrophies 2011
The differences of sarcopenia-related phenotypes: effects of gender and population
K Zhong, S Lei, F Yang, X Chen, L Tan, X Zhu, Q Tian, H Deng
European Review of Aging and Physical Activity 2011
Differential Muscle Gene Expression as a Function of Disease Progression in Goto-Kakizaki Diabetic Rats
J Nie, B Xue, S Sukumaran, WJ Jusko, DC Dubois, RR Almon
Molecular and Cellular Endocrinology 2011
Adipose Tissue Deficiency and Chronic Inflammation in Diabetic Goto-Kakizaki Rats
B Xue, S Sukumaran, J Nie, WJ Jusko, DC DuBois, RR Almon, J Vina
PloS one 2011
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1
AJ Ward, M Rimer, JM Killian, JJ Dowling, TA Cooper
Human Molecular Genetics 2010
Dramatic Improvement of Blood Glucose Control after Pioglitazone Treatment in Poorly Controlled Over-weight Diabetic Patients with Myotonic Dystrophy
H ABE, T MITA, K KUDO, T FUNAYAMA, M TOKORO, H KAGA, F IKEDA, A KANAZAWA, T HIROSE, R KAWAMORI, H WADA
Endocrine Journal 2009
Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy
K Shieh, JM Gilchrist, K Promrat
Muscle & Nerve 2009
A cross-sectional study for glucose intolerance of myotonic dystrophy
T Matsumura, H Iwahashi, T Funahashi, MP Takahashi, T Saito, K Yasui, T Saito, A Iyama, K Toyooka, H Fujimura, S Shinno
Journal of the Neurological Sciences 2009
High-fat diet induced adiposity and insulin resistance in mice lacking the myotonic dystrophy protein kinase
E Llagostera, MC Carmona, M Vicente, RM Escorihuela, P Kaliman
FEBS Letters 2009
Trinucleotide Repeat Disorders
HT Orr, HY Zoghbi
Annual Review of Neuroscience 2007
Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action
E Llagostera, D Catalucci, L Marti, M Liesa, M Camps, TP Ciaraldi, R Kondo, S Reddy, WH Dillmann, M Palacin, A Zorzano, P Ruiz-Lozano, R Gomis, P Kaliman
PloS one 2007
Role of Myotonic Dystrophy Protein Kinase (DMPK) in Glucose Homeostasis and Muscle Insulin Action
E Llagostera, D Catalucci, L Marti, M Liesa, M Camps, TP Ciaraldi, R Kondo, S Reddy, WH Dillmann, M Palacin, A Zorzano, P Ruiz-Lozano, R Gomis, P Kaliman, B McCabe
PloS one 2007
RNA-mediated neuromuscular disorders
LP Ranum, TA Cooper
Annual Review of Neuroscience 2006
RNA-dominant diseases
RJ Osborne, CA Thornton
Human Molecular Genetics 2006
Insulin Receptor Splicing Alteration in Myotonic Dystrophy Type 2
RS Savkur, AV Philips, TA Cooper, JC Dalton, ML Moseley, LP Ranum, JW Day
The American Journal of Human Genetics 2004
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
RS Savkur, AV Philips, TA Cooper
Nature Genetics 2001
Myotonic Dystrophy
G Tiscornia, MS Mahadevan
Molecular Cell 2000
Leptin after IGF-I generation test in a patient with hypopituitarism and myotonic dystrophy disease
J M Gómez, J A Martínez-Matos
Pituitary 2000
Insulin-Like Growth Factor I Circumvents Defective Insulin Action in Human Myotonic Dystrophy Skeletal Muscle Cells1
D Furling, A Marette, J Puymirat
Endocrinology 1999
Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon
D Annane, M Fiorelli, B Mazoyer, S Pappata, B Eymard, H Radvanyi, C Junien, M Fardeau, P Merlet, P Gajdos, A Syrota, Y Sansom, D Duboc
Neuromuscular Disorders 1998
Study on growth hormone and insulin secretion in myotonic dystrophy
JM Sez, JM Real, MF Castaer, MA Moreno, JA Matos, JS Ramn
The Clinical Investigator 1994
Forearm 3-methylhistidine efflux in myotonic dystrophy
Z Rifai, WJ Kingston, B McCraith, RT Moxley
Annals of Neurology 1993
Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance?
E Shmueli, KG Alberti, CO Record
Journal of Internal Medicine 1993
Glucose intolerance in first-degree relatives of patients with Friedreich's ataxia is associated with insulin resistance: Evidence for a closely linked inherited trait
IG Fantus, N Janjua, H Senni, E Andermann
Metabolism 1991
Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy
AJ Krentz, AC Williams, M Nattrass
Metabolism 1991
Mechanism of muscle wasting in myotonic dystrophy
RC Griggs, R Jozefowicz, W Kingston, KS Nair, BE Herr, D Halliday
Annals of Neurology 1990
Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy
AJ Krentz, NH Coles, AC Williams, M Nattrass
Metabolism 1990
Enhancement of insulin action after oral glucose ingestion
WJ Kingston, JN Livingston, RT 3rd
Journal of Clinical Investigation 1986
Effect of testosterone on muscle protein synthesis in myotonic dystrophy
RC Griggs, D Halliday, W Kingston, RT Moxley
Annals of Neurology 1986
Glucose intolerance in Friedreich's Ataxia: Association with insulin resistance and decreased insulin binding
RJ Khan, E Andermann, IG Fantus
Metabolism 1986
Abnormal insulin homeostasis in myotonic dystrophy
G Karpati
Trends in Neurosciences 1985
In vivo estimation of muscle protein synthesis in myotonic dystrophy
D Halliday, GC Ford, RH Edwards, MJ Rennie, RC Griggs
Annals of Neurology 1985
Whole body insulin resistance in myotonic dystrophy
RT Moxley, AJ Corbett, KL Minaker, JW Rowe
Annals of Neurology 1984
An insulin receptor defect in murine muscular dystrophy
WW Hofmann
Muscle & Nerve 1984
Muscle wasting in muscular dystrophy: Decreased protein synthesis or increased degradation?
RC Griggs, MJ Reinnie
Annals of Neurology 1983
Taurine and hyperexcitable human muscle: Effects of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles
L Durelli, R Mutani, F Fassio, A Satta, E Bartoli
Annals of Neurology 1982
Insulin receptors in myotonic dystrophy: A study with mononuclear leucocytes and erythrocytes
P Fratino, G Bellomo, R Bellazzi, PL Nicotera, G Sandrini, G Nappi
The Italian Journal of Neurological Sciences 1982
Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy
RT 3rd, JN Livingston, DH Lockwood, RC Griggs, RL Hill
Proceedings of the National Academy of Sciences 1981
Mechanisms of insulin resistance in man
RA Rizza, LJ Mandarino, JE Gerich
The American Journal of Medicine 1981
Familial Insulin Resistance with Acanthosis Nigricans, Acral Hypertrophy, and Muscle Cramps
JS Flier, JB Young, L Landsberg
New England Journal of Medicine 1980
Protein synthesis and degradation in skeletal muscle of normal and dystrophic hamsters
JB Li
American journal of physiology. Endocrinology and metabolism 1980
Metabolic implications of distal atrophy
RT Moxley, RC Griggs, WR Markesbery, V Vangelder
Journal of the Neurological Sciences 1978

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts